Chang‐Ying Guo

963 total citations
23 papers, 769 citations indexed

About

Chang‐Ying Guo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chang‐Ying Guo has authored 23 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Chang‐Ying Guo's work include Effects of Radiation Exposure (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Chang‐Ying Guo is often cited by papers focused on Effects of Radiation Exposure (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Chang‐Ying Guo collaborates with scholars based in China, Japan and Philippines. Chang‐Ying Guo's co-authors include Minh T. N. Le, Emre Basar, Leonora Balaj, Péter Hamar, Judy Lieberman, Tao‐Sheng Li, Shinji Goto, Yoshishige Urata, Lan Luo and Yan Chen and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Chang‐Ying Guo

21 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang‐Ying Guo China 10 527 396 155 108 79 23 769
Jinxiang Tan China 14 429 0.8× 253 0.6× 208 1.3× 64 0.6× 81 1.0× 21 818
Hyo Won Chang South Korea 16 477 0.9× 222 0.6× 183 1.2× 142 1.3× 68 0.9× 33 732
Feifei Cheng China 12 415 0.8× 320 0.8× 172 1.1× 50 0.5× 112 1.4× 21 736
Erandi Rajagurubandara United States 11 265 0.5× 239 0.6× 289 1.9× 93 0.9× 131 1.7× 12 787
Xinghua Han China 15 349 0.7× 289 0.7× 224 1.4× 43 0.4× 168 2.1× 54 676
Shan Pan China 14 421 0.8× 253 0.6× 100 0.6× 86 0.8× 77 1.0× 30 671
Yang Qin China 16 433 0.8× 227 0.6× 120 0.8× 54 0.5× 67 0.8× 44 643
Juan Feng China 16 567 1.1× 371 0.9× 121 0.8× 39 0.4× 107 1.4× 30 747
Byung-Kyu Ryu South Korea 12 510 1.0× 200 0.5× 210 1.4× 49 0.5× 70 0.9× 14 785

Countries citing papers authored by Chang‐Ying Guo

Since Specialization
Citations

This map shows the geographic impact of Chang‐Ying Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Ying Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Ying Guo more than expected).

Fields of papers citing papers by Chang‐Ying Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Ying Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Ying Guo. The network helps show where Chang‐Ying Guo may publish in the future.

Co-authorship network of co-authors of Chang‐Ying Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Ying Guo. A scholar is included among the top collaborators of Chang‐Ying Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Ying Guo. Chang‐Ying Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Chang‐Ying, Shengjia Chen, Yongqiang Ye, & Weimin Mao. (2023). A phase II study to evaluate anlotinib plus TQB2450 as adjuvant therapy in patients with esophageal squamous cell carcinoma (ALTER-E005).. Journal of Clinical Oncology. 41(4_suppl). TPS488–TPS488.
3.
Li, Zhao, Peng‐Fei Xu, Weimin Mao, et al.. (2022). A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).. Journal of Clinical Oncology. 40(16_suppl). e16038–e16038. 3 indexed citations
4.
5.
Jiang, Sicong, et al.. (2020). Comparison of outcomes of pedicled jejunal and colonic conduit for esophageal reconstruction. BMC Surgery. 20(1). 156–156. 6 indexed citations
6.
7.
Zhang, Xu, et al.. (2019). Nicaraven Attenuates Postoperative Systemic Inflammatory Responses-Induced Tumor Metastasis. Annals of Surgical Oncology. 27(4). 1068–1074. 16 indexed citations
8.
Guo, Chang‐Ying, et al.. (2019). The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma. BMC Cancer. 19(1). 289–289. 24 indexed citations
9.
Jiang, Sicong, et al.. (2019). Thoracic tumor resection combined with SVC replacement using autologous pericardium. World Journal of Surgical Oncology. 17(1). 227–227. 4 indexed citations
10.
Guo, Chang‐Ying, et al.. (2018). Incidence of Ipilimumab-Related Serious Adverse Events in Patients with Advanced Cancer: A Meta-Analysis. Journal of Cancer. 10(1). 120–130. 6 indexed citations
11.
Luo, Lan, Yan Chen, Yoshishige Urata, et al.. (2017). Dose-dependency and reversibility of radiation-induced injury in cardiac explant-derived cells of mice. Scientific Reports. 7(1). 40959–40959. 7 indexed citations
12.
Guo, Chang‐Ying, Yan Chen, Lan Luo, et al.. (2017). Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells. Oncology Reports. 37(4). 2161–2166. 16 indexed citations
13.
Chen, Yan, Lan Luo, Yoshishige Urata, et al.. (2017). Nicaraven, a Potential Radioprotective Agent, has Very Limited Effects on the Survival of Cancer Cells and the Growth of Established Tumors. Radiation Research. 187(3). 339–339. 7 indexed citations
14.
Chen, Yan, Lan Luo, Chang‐Ying Guo, et al.. (2016). Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells. Cancer Letters. 388. 34–42. 135 indexed citations
15.
Luo, Lan, Yoshishige Urata, Yan Chen, et al.. (2016). Radiation Exposure Decreases the Quantity and Quality of Cardiac Stem Cells in Mice. PLoS ONE. 11(5). e0152179–e0152179. 8 indexed citations
16.
Chen, Yan, Lan Luo, Shinji Goto, et al.. (2016). Enhanced autophagy in colorectal cancer stem cells does not contribute to radio-resistance. Oncotarget. 7(29). 45112–45121. 19 indexed citations
17.
Guo, Chang‐Ying, Lan Luo, Yoshishige Urata, et al.. (2015). Sensitivity and dose dependency of radiation-induced injury in hematopoietic stem/progenitor cells in mice. Scientific Reports. 5(1). 8055–8055. 26 indexed citations
18.
Li, Zengmei, Ligang Deng, Shancang Zhao, et al.. (2015). Photoluminescence properties of a new orange–red‐emitting Sm3+–La3SbO7 phosphor. Luminescence. 31(2). 462–467. 24 indexed citations
19.
Urata, Yoshishige, Shinji Goto, Chang‐Ying Guo, et al.. (2014). The potential benefits of nicaraven to protect against radiation-induced injury in hematopoietic stem/progenitor cells with relative low dose exposures. Biochemical and Biophysical Research Communications. 452(3). 548–553. 12 indexed citations
20.
Le, Minh T. N., Péter Hamar, Chang‐Ying Guo, et al.. (2014). miR-200–containing extracellular vesicles promote breast cancer cell metastasis. Journal of Clinical Investigation. 124(12). 5109–5128. 370 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinxiang Tan Breakdown of academic impact, for papers by Hyo Won Chang Breakdown of academic impact, for papers by Feifei Cheng Breakdown of academic impact, for papers by Erandi Rajagurubandara Breakdown of academic impact, for papers by Xinghua Han Breakdown of academic impact, for papers by Shan Pan Breakdown of academic impact, for papers by Yang Qin Breakdown of academic impact, for papers by Juan Feng Breakdown of academic impact, for papers by Byung-Kyu Ryu
Rankless by CCL
2026